31 August 2011
Laryngeal rhabdomyosarcoma: One case report and review of Chinese literature
Yun-Ping Fan, Shu-Lin Chen, Xin-Wei Liu, Xin-Min Gou, Wen-Tong XiaDOI: 10.12659/AJCR.881943
Am J Case Rep 2011; 12:113-117
Abstract
Abstract
Background: Laryngeal Rhabdomyosarcoma is an extremely rare malignant condition in adults, as only 17 well-documented cases have been published in the English publication. We report an adult patient with rhabdomyosarcoma of the larynx and review 30 years of Chinese literature on this disease.
Case Report: The present case is a 47-year-old man with pleomorphic subtype at histopathology; the patient was treated with total laryngectomy alone without other adjuvant therapy and has survived uneventfully thus far for 34 months. We review and discuss 17 cases of laryngeal rhabdomyosarcomas from 30 years of Chinese literature on the pathology of the tumor, diagnosis of pathology, treatment and outcome.
Conclusions: At present, surgical excision with wide margins for the tumor adjuvant by radiotherapy is optimal. An organ-sparing strategy for RA in the larynx should be seriously considered on the basis of entire tumor removal. Total laryngectomy may avoid morbidity originating from radiotherapy, but sacrifices the function of the larynx. Local excision alone or simple radiotherapy should be absolutely avoided.
Keywords: neoplasm, Laryngeal rhabdomyosarcoma, pleomorphic, Prognosis
SARS-CoV-2/COVID-19
11 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936496
09 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937505
29 July 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937105
08 July 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937212
In Press
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937598
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936743
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936466
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937063
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399